Black Diamond Therapeutics Inc (BDTX)
2.54
+0.11
(+4.53%)
USD |
NASDAQ |
Nov 22, 16:00
2.55
+0.01
(+0.39%)
After-Hours: 20:00
Black Diamond Therapeutics Free Cash Flow: -61.20M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -61.20M |
| June 30, 2024 | -68.24M |
| March 31, 2024 | -67.88M |
| December 31, 2023 | -66.75M |
| September 30, 2023 | -74.73M |
| June 30, 2023 | -72.81M |
| March 31, 2023 | -76.70M |
| December 31, 2022 | -85.27M |
| September 30, 2022 | -87.71M |
| June 30, 2022 | -99.22M |
| Date | Value |
|---|---|
| March 31, 2022 | -106.97M |
| December 31, 2021 | -102.86M |
| September 30, 2021 | -94.36M |
| June 30, 2021 | -77.88M |
| March 31, 2021 | -65.46M |
| December 31, 2020 | -52.29M |
| September 30, 2020 | -43.89M |
| June 30, 2020 | -37.72M |
| March 31, 2020 | -29.13M |
| December 31, 2019 | -24.70M |
Free Cash Flow Range, Past 5 Years
-106.97M
Minimum
Mar 2022
-24.70M
Maximum
Dec 2019
-69.79M
Average
-70.52M
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals Inc | -18.20M |
| IDEAYA Biosciences Inc | -153.27M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.32M |
| Cash from Investing (Quarterly) | 2.193M |
| Cash from Financing (Quarterly) | -0.252M |
| Free Cash Flow Per Share (Quarterly) | -0.2004 |
| Free Cash Flow Yield | -44.79% |